MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS
Clinical trials for MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for myeloma: early trial of HDP-101 targets relapsed patients
Disease control Recruiting nowThis early-phase study tests a new drug, HDP-101, in Chinese patients with multiple myeloma or similar plasma cell disorders. The goal is to find a safe dose and see if the drug can help control the cancer. About 15 adults who have already tried other treatments will take part.
Matched conditions: MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can big data unlock the secrets of plasma cell cancers?
Knowledge-focused Recruiting nowThis study is building a large database of information from thousands of people with plasma cell disorders, including multiple myeloma and related conditions. By tracking their health over many years, researchers hope to identify patterns that predict how the disease will progres…
Matched conditions: MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC